Koda Health, an innovator in digital Advance Care Planning, secures undisclosed amount in seed+ funding.
This round was led by Ecliptic Capital, with strategic investment from Memorial Hermann Health System, AARP and the Texas Medical Center (TMC) Venture Fund, underscoring the health care community’s belief in Koda’s mission, technology and impact on patient care.
Read also – IFS Acquired Copperleaf Technologies Inc
Tatiana Fofanova, PhD, CEO of Koda Health said, “If we’re looking at speed of market adoption, it’s clear that Koda Health is at the forefront of a crucial transformation in Advance Care Planning, In just a few years, we’ve built out a product that now serves well over 700,000 patients nationwide for industry giants like Cigna, Privia and Houston Methodist.”
Adam Lipman, CIO of Ecliptic Capital said, “We at Ecliptic are proud to continue our support of Koda Health’s work to provide patient education and access to Advance Care Planning, to help ensure that patients’ end-of-life wishes are honored, The team at Koda is truly dedicated to this important mission, and we are proud to back them.”
Amelia Hay, VP of Startup Programming and Investments at AgeTech Collaborative™ from AARP said, “AARP research shows that there is a willingness among older adults in the U.S. to prepare for the end of their lives, This indicates a need for more programs and services geared towards ensuring adults take the necessary steps, and AARP is pleased to invest in Koda Health to help address that need.”
Feby Abraham, PhD, Executive Vice President and Chief Strategy Officer for Memorial Hermann said, “We are always looking for new ways to further engage our patients and make them feel better supported. The unique challenges of COVID-19 have only heightened the need for innovation in this area,” “We believe investing in Koda Health will give patients the tools to make sure their wishes are carried forth and the burden is removed from their families to make those decisions.”
William McKeon, President & CEO, Texas Medical Center said,”Koda is uniquely positioned to serve payers, providers and patients, We rarely see a company that provides value to all three stakeholders. Seeing Koda launch from our TMCi BioDesign program to the progress they’ve made with our member institutions and players in the value chain is incredible.”
With the successful close of this Seed+ funding round, Koda Health is poised to accelerate its mission of revolutionizing Advance Care Planning. Leveraging the strategic partnerships and support from leading health care investors, the company is well-equipped to expand its innovative solutions and impact on patient care.
As Koda Health continues to grow, its dedication to ensuring patients’ wishes are honored remains steadfast, further cementing its position as a leader in the health care industry and setting new standards in patient care and education.
About Koda Health
Koda Health is a tech-enabled care coordination service to improve serious illness care planning. Its Advance Care Planning (ACP) solution pairs a cloud-based ACP platform with an in-house 1:1 longitudinal ACP support and navigation. This allows healthcare organizations to provide scalable, personalized ACP without an increased organizational lift.
